24 June 2024 in Diabetic Medicine
Aims: In tackling rising diabetes‐related emergencies, the need to understand and address emergency service usage by people with type 1 diabetes is vital. This review aimed to quantify current trends in presentations for type 1 diabetes‐related emergencies and identify public health strategies that reduce the frequency of diabetes‐related emergencies and improve glycaemic management.Methods: Medline (OVID), Cochrane and CINAHL were searched for studies published between 2000 and 2023, focusing on people with type 1 diabetes, severe hypoglycaemia and/or diabetic ketoacidosis, and ambulance and/or emergency department usage. There were 1313 papers identified, with 37 publications meeting review criteria.Results: The incidence of type 1 diabetes‐related emergencies varied from 2.4 to 14.6% over one year for hypoglycaemic episodes, and between 0.07 and 11.8 events per 100 person‐years for hyperglycaemic episodes. Notably, our findings revealed that ongoing diabetes education and the integration of diabetes technology, such as continuous glucose monitoring and insulin pump therapy, significantly reduced the incidence of these emergencies. However, socio‐economic disparities posed barriers to accessing these technologies, subsequently shifting the cost to emergency healthcare and highlighting the need for governments to consider subsidising these technologies as part of preventative measures.Conclusions: Improving access to continuous glucose monitoring and insulin pump therapy, in combination with ongoing diabetes education focusing on symptom recognition and early management, will reduce the incidence of diabetes‐related emergencies. Concurrent research assessing emergency healthcare usage patterns during the implementation of such measures is essential to ensure these are cost‐effective.
29 November 2023 in Emergency Medicine Australasia
10 August 2026 in JGH Open
Background: Terminal ileitis is a common radiological finding in patients with abdominal pain and altered bowel habits. Although often associated with Crohn's disease (CD), it has a broad differential diagnosis including infectious, surgical, and malignant conditions. Prior studies suggest 20%–45% of terminal ileitis accounts for CD. This study aimed to evaluate the proportion of patients with computed tomography‐detected (CT) terminal ileitis diagnosed with CD and to assess clinical and biochemical predictors. Methods: A retrospective cohort study was conducted at a single tertiary hospital between 2014 and 2024. Adult patients with CT findings of terminal ileitis were included. Data were collected on demographics, laboratory values, stool testing, and endoscopic evaluation. Multivariable logistic regression was used to identify predictors of CD. Results: Of 128 patients, 16 (12.5%) were diagnosed with CD. Infectious (27.7%) and surgical (17.9%) etiologies were the most common causes of non‐CD terminal ileitis. Stool testing within 72 h was performed for 48.4% of patients, with 35.5% positive for pathogens. Endoscopic evaluation was performed in 59 patients (46%), and histopathological inflammation identified in 43.5% of biopsied cases. Lower albumin levels trended toward association with CD and were independently associated with CD on multivariable analysis (OR 0.82, 95% CI 0.72–0.94, p = 0.004). Conclusions: After evaluation, a small minority (12.5%) of patients with CT‐detected terminal ileitis were diagnosed with CD. Hypoalbuminemia was a significant predictor of CD, whereas routine inflammatory markers had limited diagnostic value. Larger prospective studies are needed to further refine the diagnostic algorithms for detection of CD in patients with terminal ileitis.